Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

518 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry.
Malavasi VL, Vitolo M, Proietti M, Diemberger I, Fauchier L, Marin F, Nabauer M, Potpara TS, Dan GA, Kalarus Z, Tavazzi L, Maggioni AP, Lane DA, Lip GYH, Boriani G; ESC-EHRA EORP-AF Long-Term General Registry Investigators. Malavasi VL, et al. Among authors: fauchier l. Eur J Clin Invest. 2022 Jul;52(7):e13773. doi: 10.1111/eci.13773. Epub 2022 Mar 28. Eur J Clin Invest. 2022. PMID: 35305020
Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
Marijon E, Trinquart L, Otmani A, Waintraub X, Kacet S, Clémenty J, Chatellier G, Le Heuzey JY; Evaluation Médico-Economique du Défibrillateur Automatique Implantable (EVADEF) Investigators. Marijon E, et al. Am Heart J. 2009 Feb;157(2):391-397.e1. doi: 10.1016/j.ahj.2008.09.023. Epub 2008 Dec 3. Am Heart J. 2009. PMID: 19185651 Clinical Trial.
Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study.
Marijon E, Trinquart L, Otmani A, Leclercq C, Fauchier L, Chevalier P, Klug D, Defaye P, Lellouche N, Mansourati J, Deharo JC, Sadoul N, Anselme F, Maury P, Davy JM, Extramiana F, Hidden-Lucet F, Probst V, Bordachar P, Mansour H, Chauvin M, Jouven X, Lavergne T, Chatellier G, Le Heuzey JY; EVADEF Investigators. Marijon E, et al. Among authors: fauchier l. Am Heart J. 2010 Apr;159(4):659-664.e1. doi: 10.1016/j.ahj.2010.01.011. Am Heart J. 2010. PMID: 20362726 Clinical Trial.
Impact of early statin therapy on development of atrial fibrillation at the acute stage of myocardial infarction: data from the FAST-MI register.
Danchin N, Fauchier L, Marijon E, Barnay C, Furber A, Mabo P, Bernard P, Blanc JJ, Jouven X, Le Heuzey JY, Charbonnier B, Ferrières J, Simon T; French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) Investigators. Danchin N, et al. Among authors: fauchier l. Heart. 2010 Nov;96(22):1809-14. doi: 10.1136/hrt.2010.201574. Heart. 2010. PMID: 20965993
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.
Lip GY, Andreotti F, Fauchier L, Huber K, Hylek E, Knight E, Lane DA, Levi M, Marin F, Palareti G, Kirchhof P; Document reviewers:; Collet JP, Rubboli A, Poli D, Camm J. Lip GY, et al. Among authors: fauchier l. Europace. 2011 May;13(5):723-46. doi: 10.1093/europace/eur126. Europace. 2011. PMID: 21515596
New antithrombotic drugs and European approval processes.
Marijon E, Fauchier L, Le Heuzey JY. Marijon E, et al. Among authors: fauchier l. Lancet. 2011 Aug 20;378(9792):662-3. doi: 10.1016/S0140-6736(11)61327-5. Lancet. 2011. PMID: 21856473 No abstract available.
518 results